Skip to main content
Log in

Pharmacokinetics of perhexiline maleate in anginal patients with and without peripheral neuropathy

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Perhexiline maleate (Pexid ®) which has been in general use in France with good results for the treatment of angina pectoris since 1973, may be associated with severe side effects including peripheral neuropathy. The present study is a comparison of the pharmacokinetics of perhexiline maleate in anginal patients with and without signs of peripheral neuropathy. Compared to the latter, those with neuropathy had higher plasma levels of perhexiline, slower hepatic metabolism and a longer plasma half-life. Thus, peripheral neuropathy associated with perhexiline maleate treatment appears to be a direct toxic effect due to accumulation of the drug. The accumulation might result either from a decreased volume of distribution secondary to a loss of body weight, possibly drug-induced, or to slow hepatic metabolism of perhexiline of genetic origin or due to hepatic disease, possibly drug-induced. The neuropathy is rarely an isolated event, as it is often associated with one or more adverse effects of perhexiline.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Feldman, G.: Hypoglycémic et perhexiline. Nouv. Presse Méd.3, 2580 (1974)

    Google Scholar 

  2. Roger, P., Noguc, F., Ragnaud, J. M., Manciet, G., Doumax, Y.: Hypoglycémie après maleate de perhexiline. Nouv. Presse Méd.4, 2263 (1975)

    Google Scholar 

  3. Sudre, Y., Belq-Giraudon, P., Pouget-Abadie, J., Demange, J., Boutaud, P.: Rôle du maleate de perhexiline et des β bloqueurs dans l'apparition d'hypoglycémies graves. Nouv. Presse Méd.5, 1999 (1976)

    Google Scholar 

  4. Dally, S., Lagier, G., Assan, R., Gaultier, M.: Hypoglycémie chez deux patients traités par le maleate de perhexiline. Nouv. Presse Méd.6, 1643–1649 (1977)

    Google Scholar 

  5. Grand, A., Sepulchre, P.: Amaigrissement et maleate de perhexiline. Nouv. Presse Méd.3, 2580 (1974)

    Google Scholar 

  6. Howard, D., Russel, J.: Long term perhexiline maleate and liver function. Br. med. J.1976/I, 133

    Google Scholar 

  7. Beaugrand, M.: Hépatite médicamenteuse à la perhexiline. Nouv. Presse Méd.5, 1695 (1976)

    Google Scholar 

  8. Beaugrand, M., Poupon, R., Callard, P., Lageron, A., Levy, V. G., De Saint Maur, P. P., Ferrier, J. P., Darnis, F.: Hépatites au maléate de perhexiline. Gastroentérol. clin. Biol.1, 705–706 (1977)

    Google Scholar 

  9. Bourrat, C., Viala, J. J., Guastala, J. P.: Neuropathies périphériques après absorption prolongée de maléate de perhexiline. Nouv. Presse Méd.4, 2558 (1975)

    Google Scholar 

  10. Bousser, M. G., Bouche, P., Brochard, C., Herreman, G.: Neuropathies périphériques au maléate de perhexiline. Coeur Méd. Inter.15 181–188 (1976)

    Google Scholar 

  11. Lhermitte, F., Fardeau, M., Chedru, F., Mallecourt, J.: Polyneuropathy after perhexiline maleate therapy. Br. med. J.748, 1256–1257 (1976)

    Google Scholar 

  12. Nicolas, G., Delobel, R., Feve, J. R., Rozo, L.: Neuropathie périphérique secondaire à la prise de maléate de perhexiline. Ann. Med. Interne127, 607–610 (1976)

    Google Scholar 

  13. Bousser, M. G., Bouche, P., Brochard, C., Herreman, G.: Sept neuropathies périphériques après traitement par maléate de perhexiline. Nouv. Presse Méd.5, 652–653 (1976)

    Google Scholar 

  14. Leeson, G. A., Lang, J. F., Zeiger, A. V., Hudak, J. W., Wright, G. J.: Excretion, blood levels and tissue retention of perhexiline 14 C maleate in dogs. Pharmacologist11, 280–286 (1969)

    Google Scholar 

  15. Leeson, G. A., Zeiger, A. V., Lang, J. F., Wright, G. J.: Metabolic fate of perhexiline 14 C maleate. Fed. Proc.28, 798–802 (1969)

    Google Scholar 

  16. Leeson, G. A., Zeiger, A. V., Lang, J. F., Wright, G. J.: Distribution of perhexiline and its metabolites in rat. 5th Int. Congr. Pharmacology, San Francisco, 23–28 juillet 1972, p. 137

  17. Wright, G. J., Leeson, G. A., Zeiger, A. V., Lang, J. F.: The absorption, excretion and metabolism of perhexiline maleate by the human. Postgrad. Med. J.49, 8–15 (1973)

    Google Scholar 

  18. Wright, G. J., Zeiger, A. V., Leeson, G. A., Lang, J. F.: Biotransformation and pharmacokinetics of perhexiline maleate in the human. 6th. Int. Congr. Pharmacology, Helsinki, 20–25 juillet 1975, p. 451

  19. Wright, G. J.: Personal Communication (1976)

  20. Singlas, E., Goujet, M. A., Simon, P.: Maleate de perhexiline: relations entre effects secondaires, concentrations plasmatiques et vitesse de métabolisme. Nouv. Presse Méd.7, 1631–1632 (1978)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Singlas, E., Goujet, M.A. & Simon, P. Pharmacokinetics of perhexiline maleate in anginal patients with and without peripheral neuropathy. Eur J Clin Pharmacol 14, 195–201 (1978). https://doi.org/10.1007/BF02089960

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02089960

Key words

Navigation